News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Boston Scientific Corporation Unit, Guidant Corporation Pleads Guilty in DOJ Case; Penalties Total More Than $296 Million
April 6, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Guidant LLC, a unit of Boston Scientific Corp (BSX.N), plead guilty on Monday to criminal charges related to short-circuiting failures in three models of its implantable heart defibrillators, according to the U.S. Justice Department.
Twitter
LinkedIn
Facebook
Email
Print
Legal
MORE ON THIS TOPIC
Patents
Pfizer settles with generic drugmakers to protect blockbuster drug until 2031
April 29, 2026
·
2 min read
·
Nick Paul Taylor
Pancreatic cancer
Revolution levels legal threat on Erasca as pancreatic cancer rivalry heats up
April 28, 2026
·
3 min read
·
Tristan Manalac
Drug pricing
Regeneron finally joins Trump’s drug pricing push while notching landmark approval
April 24, 2026
·
2 min read
·
Tristan Manalac
Complete response letters
Unnamed pharma files citizen petition targeting FDA’s trove of rejection letters
April 23, 2026
·
2 min read
·
Tristan Manalac